News - Page 59 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Revive Therapeutics Provides Update From Type C Meeting with FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Revive Therapeutics Provides Update From Type C Meeting with FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Post published:March 8, 2023
Post category:Press Release

Read more about the article BetterLife Announces Offering of Units

BetterLife Announces Offering of Units

Post published:March 8, 2023
Post category:Press Release

Read more about the article Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

Post published:March 7, 2023
Post category:Press Release

Read more about the article Inside Synthesis Institute’s Implosion

Inside Synthesis Institute’s Implosion

Post published:March 7, 2023
Post category:Analysis

Read more about the article Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference

Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference

Post published:March 7, 2023
Post category:Press Release

Read more about the article Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results

Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results

Post published:March 7, 2023
Post category:Press Release

Read more about the article Numinus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest Conference

Numinus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest Conference

Post published:March 7, 2023
Post category:Press Release

Read more about the article atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates

atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates

Post published:March 6, 2023
Post category:Press Release

Read more about the article Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales Partnership

Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales Partnership

Post published:March 6, 2023
Post category:Press Release

Read more about the article Psychedelic Bulletin #132: COMPASS Pathways Amends Phase 3 Program; Stamets Stack Finally Patented; Learning from Zuranolone?

Psychedelic Bulletin #132: COMPASS Pathways Amends Phase 3 Program; Stamets Stack Finally Patented; Learning from Zuranolone?

Post published:March 5, 2023
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.